What do people make of the move from the PER.C6 cell line to the CHO method?
Does this throw negative light back on Patrys ability to produce at scale using their own methods or does it show that large pharma is serious about the drug and wants to know if it can produce it with their preferred method?
I think this is a major announcement and fundamental change to the company.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.1¢ |
Change
-0.001(50.0%) |
Mkt cap ! $2.365M | |||
| Open | High | Low | Value | Volume |
| 0.1¢ | 0.2¢ | 0.1¢ | $7.467K | 4.095M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 46 | 115294083 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 52771391 | 23 |
View Market Depth
| Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
| PAB (ASX) Chart |